Abstract
Photodynamic therapy (PDT) using 5-aminolevulinic acid (ALA)-induced protoporphyrin IX (PpIX) (ALA-PDT) is useful for treating nonmelanoma skin cancers, actinic keratosis and psoriasis, in addition to several other cutaneous indications12. In Bowen's disease in light skin types, ALA-PDT resolves an average of 86% to 93% of lesions following 1 or 2 treatments 3. ALA-PDT is a particularly good option for unusual sites or poor healing lesions because of its good cosmetic and functional outcomes.
Cite
CITATION STYLE
Kosaka, S., & Kawana, S. (2010). A case of Bowen’s disease successfully treated by photodynamic therapy. Journal of Nippon Medical School, 77(3), 136–137. https://doi.org/10.1272/jnms.77.136
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
